Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
---|
03/25/2004 | WO2003087050A3 Novel perindopril salt and pharmaceutical compositions containing same |
03/25/2004 | WO2003072528A3 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
03/25/2004 | US20040059109 Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics |
03/25/2004 | US20040058936 Dietetics, sexual disorders, antidiabetic agents |
03/25/2004 | CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
03/24/2004 | EP1399444A2 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
03/24/2004 | EP1399423A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
03/24/2004 | EP1399146A1 Novel compounds and compositions as cathepsin inhibitors |
03/24/2004 | EP0904079B1 Antidiabetic agents |
03/24/2004 | CN1142913C Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions contg. same |
03/18/2004 | WO2004007459A3 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
03/18/2004 | US20040053961 Excitatory amino acid receptor antagonists |
03/18/2004 | US20040053960 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
03/18/2004 | US20040053932 Peptide deformylase inhibtors |
03/18/2004 | US20040053907 Cell adhesion inhibitors |
03/18/2004 | US20040053890 Naphthalene derivatives |
03/17/2004 | EP1397350A1 Isoquinolinone derivatives as parp inhibitors |
03/17/2004 | EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents |
03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
03/17/2004 | CN1483033A Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
03/11/2004 | WO2004005279A3 Substituted anthranilic amide derivatives and methods of use |
03/11/2004 | WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators |
03/11/2004 | US20040048904 E.g., 1-(pyridin-4-ylcarbamoyl)-1,2,3,6- tetrahydropyridine hydrochloride; treating and/or preventing amnesia or dementia |
03/11/2004 | US20040048797 Regulation of TNF-alpha |
03/11/2004 | DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
03/10/2004 | EP1396488A1 Fused heterocyclic compound and medicinal use thereof |
03/10/2004 | EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
03/09/2004 | US6703405 Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them |
03/09/2004 | US6703403 Method for improving pharmacokinetics |
03/09/2004 | US6703392 Orexin receptor antagonists for obesity or sleeping disorder treatment |
03/09/2004 | US6703391 Quinoxalinedione derivatives, their preparation and use |
03/04/2004 | WO2004018414A2 Antibacterial agents |
03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |
03/04/2004 | WO2003040402A3 Alpha-helix mimicry by a class of organic molecules |
03/04/2004 | US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors |
03/04/2004 | US20040044211 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
03/04/2004 | US20040044031 Controlling appetite; dietetics; sleep disorders |
03/04/2004 | US20040044030 Cardiovascular disorders; antiarrhythmia agents |
03/04/2004 | US20040044000 Cardiovascular disorders; antiarthritic agents; inflammatory bowel disorders; vision defects; respiratory system disorders |
03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
03/03/2004 | EP1392639A1 Pyruvate derivatives |
03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
03/03/2004 | EP1392363A2 Compositions and uses of mglur5 antagonists |
03/03/2004 | EP1392306A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
03/02/2004 | US6699891 Npyy5 antagonists |
03/02/2004 | US6699890 Phosphodiesterase 4 inhibitors |
03/02/2004 | US6699651 Base precursors for use in a photothermographic element |
02/26/2004 | WO2004016583A1 Substituted glycine derivatives for use as medicaments |
02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
02/26/2004 | US20040038959 Treating osteoarthritis or rheumatoid arthritis |
02/26/2004 | US20040037022 Aminoalcohol derivatives |
02/26/2004 | CA2494546A1 Substituted glycine derivatives for use as medicaments |
02/25/2004 | EP1200409B1 Substituted isoquinoline derivatives and their use as anticonvulsants |
02/25/2004 | EP1042296B1 Substituted isoquinoline derivatives and their use as anticonvulsants |
02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
02/25/2004 | EP0984967B1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
02/25/2004 | CN1477100A Compound with activity for resisting platelet agregation and its preparation method |
02/25/2004 | CN1139576C Process for preparation of optically active (R)-or (S)-1-(4-methoxy-benzyl)-8-octahydro-isoquinoline |
02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
02/24/2004 | US6696481 Immediate-release tablets; treatment of arterial hypertension and heart failure |
02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
02/19/2004 | WO2004014379A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
02/19/2004 | WO2004014378A1 3-isoquinolinone derivatives as matrix metalloproteinase inhiitors |
02/19/2004 | WO2003065989A3 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
02/19/2004 | US20040034104 2,2-Diphenylbutanamide derivatives and medicines containing the same |
02/19/2004 | US20040034056 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide |
02/19/2004 | US20040034011 Administering to a mammal a napthalene derivative containing at least two hydroxy groups at ortho position to one another, for the treatment of disorders caused by catechol-O-methyltransferase enzyme |
02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
02/19/2004 | CA2492019A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
02/18/2004 | EP1389611A1 20-hydroxyeicosatetraenoic acid production inhibitors |
02/18/2004 | EP1389194A2 Inhibitors of bace |
02/18/2004 | EP1389103A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
02/18/2004 | CN1476436A Novel compounds for use as HIV protease inhibitors |
02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
02/12/2004 | WO2003062261A3 Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use |
02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
02/12/2004 | US20040030131 Central nervous system disorders |
02/12/2004 | US20040029898 Anticancer agents |
02/12/2004 | US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders |
02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
02/11/2004 | EP1387839A1 Process for the production of quinazolines |
02/11/2004 | EP1224177B1 Process for preparing oxazolines from tetrahydrofurans |
02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
02/05/2004 | US20040024211 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes |
02/05/2004 | US20040024210 New compounds |
02/05/2004 | US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
02/04/2004 | EP1386317A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer |
02/04/2004 | EP1385823A1 Novel guanidino compounds |